Oncolytic viral therapy for pancreatic cancer: current research and future directions.

IF 6.7 Oncolytic Virotherapy Pub Date : 2014-02-17 eCollection Date: 2014-01-01 DOI:10.2147/OV.S53858
Justin W Ady, Jacqueline Heffner, Elizabeth Klein, Yuman Fong
{"title":"Oncolytic viral therapy for pancreatic cancer: current research and future directions.","authors":"Justin W Ady,&nbsp;Jacqueline Heffner,&nbsp;Elizabeth Klein,&nbsp;Yuman Fong","doi":"10.2147/OV.S53858","DOIUrl":null,"url":null,"abstract":"<p><p>The development of targeted agents and chemotherapies for pancreatic cancer has only modestly affected clinical outcome and not changed 5-year survival. Fortunately the genetic and molecular mechanisms underlying pancreatic cancer are being rapidly uncovered and are providing opportunities for novel targeted therapies. Oncolytic viral therapy is one of the most promising targeted agents for pancreatic cancer. This review will look at the current state of the development of these self-replicating nanoparticles in the treatment of pancreatic cancer. </p>","PeriodicalId":19491,"journal":{"name":"Oncolytic Virotherapy","volume":"3 ","pages":"35-46"},"PeriodicalIF":6.7000,"publicationDate":"2014-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/OV.S53858","citationCount":"13","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncolytic Virotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/OV.S53858","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2014/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 13

Abstract

The development of targeted agents and chemotherapies for pancreatic cancer has only modestly affected clinical outcome and not changed 5-year survival. Fortunately the genetic and molecular mechanisms underlying pancreatic cancer are being rapidly uncovered and are providing opportunities for novel targeted therapies. Oncolytic viral therapy is one of the most promising targeted agents for pancreatic cancer. This review will look at the current state of the development of these self-replicating nanoparticles in the treatment of pancreatic cancer.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
胰腺癌的溶瘤病毒治疗:研究现状及未来方向。
胰腺癌靶向药物和化疗的发展仅对临床结果有轻微影响,并没有改变5年生存率。幸运的是,胰腺癌的遗传和分子机制正在迅速被发现,并为新的靶向治疗提供了机会。溶瘤病毒治疗是胰腺癌最有前途的靶向药物之一。这篇综述将着眼于这些自我复制纳米颗粒在胰腺癌治疗中的发展现状。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
16 weeks
期刊最新文献
The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment. Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib. Virus-Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Development. Impact of Induced Syncytia Formation on the Oncolytic Potential of Myxoma Virus. Virus-Receptor Interactions: Structural Insights For Oncolytic Virus Development.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1